Showing 76–100 of 6,864 international scientific journals
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 76 | Current Opinion in Allergy and Clinical Immunology ISSN: 1528-4050 / 1473-6322 | 🇺🇸United States | Q2 | CAS Tier 3 | 2.8 | 0.798Q2 | 76 | 74 | 6.7% | Lippincott Williams and Wilkins Ltd. | Profile |
| 77 | Expert Review of Medical Devices ISSN: 1743-4440Top Tier | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.8 | 0.548Q2 | 55 | 123 | 6.9% | Taylor and Francis Ltd. | Profile |
| 78 | Genesis ISSN: 1526-968X | 🌐International | Q2 | CAS Tier 4 | 2.8 | — | 100 | 1 | 0% | Updating | Profile |
| 79 | Genesis ISSN: 1526-954X / 1526-968X | 🇺🇸United States | Q2 | CAS Tier 4 | 2.8 | 0.87Q2 | 101 | 37 | 0% | Wiley-Liss Inc. | Profile |
| 80 | Human Cell ISSN: 1749-0774 / 0914-7470 | 🇯🇵Japan | Q3 | CAS Tier 3 | 2.8 | 0.854Q2 | 32 | 162 | 0% | Springer Singapore | Profile |
| 81 | Human Cell ISSN: 0914-7470 / 1749-0774 | 🌐Australia | Q3 | CAS Tier 3 | 2.8 | — | 33 | 162 | 0% | Springer Singapore | Profile |
| 82 | Journal of Operational Oceanography ISSN: 1755-876X / 1755-8778 | 🇬🇧United Kingdom | Q3 | CAS Tier 4 | 2.8 | 0.657Q2 | 19 | 24 | 0% | Taylor and Francis Ltd. | Profile |
| 83 | Local Environment ISSN: 1354-9839 / 1469-6711 | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.8 | 0.91Q1 | 53 | 109 | 4.2% | Routledge | Profile |
| 84 | Nitrogen ISSN: 2504-3129 | 🇨🇭Switzerland | Q3 | CAS Tier 4 | 2.8 | 0.527Q2 | — | 69 | 6.2% | MDPI AG | Profile |
| 85 | Organoids ISSN: 2674-1172 | 🌐International | Q3 | — | 2.8 | 0.813Q2 | — | — | N/A | Updating | Profile |
| 86 | Photochem ISSN: 2673-7256 | 🌐International | Q3 | CAS Tier 3 | 2.8 | 0.496Q2 | — | — | N/A | Updating | Profile |
| 87 | Revista Espanola De Quimioterapia ISSN: 0214-3429Diamond OA | 🌐Spain | Q3 | CAS Tier 4 | 2.8 | 0.611Q2 Diamond OA | 23 | 93 | 10.5% | Sociedad Espanola de Quiminoterapia | Profile |
| 88 | Tissue Engineering Part A ISSN: 1937-3341 / 1937-335X | 🇺🇸United States | Q3 | CAS Tier 3 | 2.8 | 0.704Q2 | 98 | 70 | 2.9% | Mary Ann Liebert Inc. | Profile |
| 89 | Tissue Engineering. Part a ISSN: 1076-3279 | 🇺🇸United States | Q3 | — | 2.8 | — | — | 391 | N/A | Updating | Profile |
| 90 | Traffic ISSN: 1398-9219 / 1600-0854 | 🌐Denmark | Q3 | CAS Tier 3 | 2.8 | 1.277Q1 | 119 | 33 | 2.8% | Blackwell Munksgaard | Profile |
| 91 | ACM Transactions on Asian and Low-Resource Language Information Processing ISSN: 2375-4699 / 2375-4702 | 🇺🇸United States | Q3 | CAS Tier 4 | 2.7 | 0.574Q2 | 6 | 106 | 22.2% | Association for Computing Machinery (ACM) | Profile |
| 92 | Advances in Building Energy Research ISSN: 1751-2549 / 1756-2201 | 🇬🇧United Kingdom | Q2 | CAS Tier 4 | 2.7 | 0.647Q2 | — | 39 | 14.3% | Taylor & Francis | Profile |
| 93 | Applied Clinical Informatics ISSN: 1869-0327 | 🇩🇪Germany | Q3 | CAS Tier 3 | 2.7 | 0.798Q2 | 20 | 123 | 28.6% | Schattauer GmbH | Profile |
| 94 | Biology of the Cell ISSN: 0248-4900 / 1768-322X | 🇬🇧United Kingdom | Q3 | CAS Tier 3 | 2.7 | 0.931Q1 | 77 | 24 | 4.2% | Wiley-Blackwell | Profile |
| 95 | Cellular Reprogramming ISSN: 2152-4971 / 2152-4998 | 🇺🇸United States | Q3 | CAS Tier 4 | 2.7 | 0.553Q2 | 57 | 29 | 0% | Mary Ann Liebert Inc. | Profile |
| 96 | Chinese Clinical Oncology ISSN: 2304-3865 / 2304-3873 | 🌐Hong Kong | Q3 | CAS Tier 4 | 2.7 | 0.636Q2 | — | 48 | 4.8% | AME Publishing Company | Profile |
| 97 | Corrosion and Materials Degradation ISSN: 2624-5558 | 🇨🇭Switzerland | Q3 | CAS Tier 3 | 2.7 | 0.549Q2 | — | 32 | N/A | MDPI AG | Profile |
| 98 | Energy Systems-Optimization Modeling Simulation and Economic Aspects ISSN: 1868-3967 / 1868-3975 | 🇩🇪Germany | Q4 | CAS Tier 4 | 2.7 | 0.568Q2 | — | 93 | 4.8% | Springer Nature | Profile |
| 99 | Frontiers in Communications and Networks ISSN: 2673-530X | 🇨🇭Switzerland | Q3 | CAS Tier 4 | 2.7 | 0.754Q2 | — | 34 | 0% | Frontiers Media S.A. | Profile |
| 100 | Frontiers in Dementia ISSN: 2813-3919 | 🌐International | Q3 | — | 2.7 | 0.526Q2 | — | — | N/A | Updating | Profile |